Does RISPERIDONE Cause Mobility decreased? 104 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 104 reports of Mobility decreased have been filed in association with RISPERIDONE (Risperidone). This represents 0.1% of all adverse event reports for RISPERIDONE.
104
Reports of Mobility decreased with RISPERIDONE
0.1%
of all RISPERIDONE reports
17
Deaths
47
Hospitalizations
How Dangerous Is Mobility decreased From RISPERIDONE?
Of the 104 reports, 17 (16.3%) resulted in death, 47 (45.2%) required hospitalization, and 4 (3.8%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 104 reports have been filed with the FAERS database.
What Other Side Effects Does RISPERIDONE Cause?
Gynaecomastia (24,453)
Off label use (10,376)
Abnormal weight gain (9,418)
Weight increased (6,885)
Emotional disorder (5,809)
Product use in unapproved indication (5,551)
Drug ineffective (5,232)
Injury (4,447)
Hyperprolactinaemia (4,124)
Galactorrhoea (3,513)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which RISPERIDONE Alternatives Have Lower Mobility decreased Risk?
RISPERIDONE vs RITALIN
RISPERIDONE vs RITLECITINIB
RISPERIDONE vs RITODRINE
RISPERIDONE vs RITONAVIR
RISPERIDONE vs RITUXAN